Related Experiment Video

Updated: Jul 18, 2025

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

33.5K

Antithrombotic Management in AF Patients Following Percutaneous Coronary Intervention: A European Perspective

Antonio Greco1, Claudio Laudani1, Carla Rochira1

  • 1Azienda Ospedaliero-Universitaria Policlinico 'G. Rodolico - San Marco', University of Catania Catania, Italy.

Interventional Cardiology (London, England)
|August 21, 2023
PubMed

Insights

Managing patients with atrial fibrillation (AF) and undergoing percutaneous coronary intervention (PCI) requires balancing antithrombotic therapies. This review examines strategies to reduce bleeding risk while preventing thrombotic events in AF patients post-PCI.

Area of Science:

  • Cardiology
  • Pharmacology
  • Clinical Medicine

Background:

  • Atrial fibrillation (AF) is a common condition necessitating long-term oral anticoagulation to prevent thromboembolic events.
  • Coronary artery disease frequently coexists with AF, often requiring percutaneous coronary intervention (PCI) and dual antiplatelet therapy (DAPT).
  • The concurrent management of AF and PCI presents a significant clinical challenge due to the need for both anticoagulation and DAPT, leading to triple antithrombotic therapy.

Purpose of the Study:

  • To analyze the mechanisms of thrombotic complications in patients with AF undergoing PCI.
  • To review current evidence on various antithrombotic therapy regimens for this patient population.
  • To discuss the latest European guidelines for managing antithrombotic therapy in AF patients post-PCI.

Main Methods:

  • Literature review focusing on thrombotic mechanisms and antithrombotic strategies.
  • Analysis of clinical trial data and observational studies on triple antithrombotic therapy.
  • Synthesis of recommendations from recent European Society of Cardiology (ESC) guidelines.

Main Results:

  • Triple antithrombotic therapy, while theoretically indicated, significantly increases bleeding risk.
  • Strategies like shortening the duration of triple therapy or switching to dual therapy are being investigated to mitigate bleeding.
  • Evidence supports tailored antithrombotic approaches based on individual patient risk profiles.

Conclusions:

  • Optimizing antithrombotic therapy in AF patients undergoing PCI is crucial for balancing efficacy and safety.
  • Current guidelines suggest individualized treatment strategies to minimize bleeding complications.
  • Further research is needed to refine optimal antithrombotic regimens for this complex patient group.

Keywords:
AFAnticoagulantsantiplatelet agentsantithrombotic therapycoronary artery diseasepercutaneous coronary intervention

More Related Videos

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

83.7K
Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology10:46

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology

Published on: May 26, 2015

13.4K

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
10
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
12
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
11
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
11
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
9
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
12